L-asparaginase

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Ma-Spore ALL 2020 Study

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia

VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study

LAL-BR/2001: Study Treatment to Low Risk ALL

LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma